Morphine Induced Changes in Ethanol-and Water-intake Are Attenuated by the 5-HT3/4 Antagonist Tropisetron (ICS 205-930)
Overview
Authors
Affiliations
The opiate agonist morphine has been shown to increase ethanol intake and mesolimbic dopamine (DA) levels. Conversely, the 5-HT3/4 antagonist tropisetron has been shown to decrease ethanol intake and morphine-induced increases in mesolimbic DA levels. This study was designed to test the effects of acutely administered tropisetron on morphine-induced changes in ethanol (6% v/v) and water intake in a two-bottle test procedure. Ten water restricted male rats were injected with combinations of morphine (0.0, 0.56, 1.0, 1.5, 10.0, and 17.0 mg/kg, SC) and tropisetron (0.0, 1.0, 10.0, and 17.0 mg/kg, SC) prior to test sessions. Morphine (1.0 and 1.5 mg/kg) significantly increased absolute (g/kg) and relative ethanol intake (ethanol/total fluid). Tropisetron alone did not affect ethanol or water intake. When tropisetron (10.0 and 17.0 mg/kg) was administered in combination with morphine (1.5 mg/kg), the increase in ethanol intake induced by morphine was attenuated. Tropisetron (1.0 mg/kg) reversed a decrease in ethanol intake induced by morphine (17.0 mg/kg). The two highest doses of tropisetron partially attenuated a significant decrease in water intake produced by morphine (17.0 mg/kg). These data suggest that opiate and 5-HT3 mechanisms could interact in the regulation of ethanol intake. However, the doses of tropisetron tested were high and, therefore, the potential involvement of 5-HT4 receptors or other neurotransmitter systems in regulating ethanol intake is discussed.
Zheng J, Han W, Han X, Ma X, Zhang P Medicine (Baltimore). 2016; 95(48):e5074.
PMID: 27902584 PMC: 5134765. DOI: 10.1097/MD.0000000000005074.
Ginsburg B, Lamb R Br J Pharmacol. 2014; 171(14):3499-510.
PMID: 24697498 PMC: 4105936. DOI: 10.1111/bph.12707.
Platt D, Bano K Eur J Pharmacol. 2010; 650(1):233-9.
PMID: 20940013 PMC: 2997855. DOI: 10.1016/j.ejphar.2010.09.064.
Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla E Psychopharmacology (Berl). 2007; 192(4):537-46.
PMID: 17345066 DOI: 10.1007/s00213-007-0746-7.
Hodge C, Slawecki C, Aiken A Alcohol Clin Exp Res. 1996; 20(9):1669-74.
PMID: 8986220 PMC: 4266412. DOI: 10.1111/j.1530-0277.1996.tb01714.x.